News

Izotropic CEO & COO Interview - Izoview REVEAL! (CSE:IZO)

Izotropic CEO Interview - Prototype REVEAL SOON! (CSE:IZO)

Izotropic CEO Interview - United States Transition! (CSE:IZO)

Justin welcomes Dr. John McGraw on the show today to discuss why Izotropic is transitioning to the United States and how the transition will help grow the company even faster!

Izotropic CEO Interview - Clinical Trial & CRO Updates! (CSE:IZO)

Izotropic CEO Dr. John McGraw joins Justin today to give updates on how clinical trials are going for the company. Dr. John McGraw explains to the audience what a CRO is, Izotropic chose Icon as the company's CRO after a lengthy interview process. These are some of the steps Izotropic has to take to get the company to commercialization.

Izotropic CEO Interview - Prototype Updates! (CSE:IZO)

Justin welcomes Izotropic CEO Dr. John McGraw, to discuss prototype updates, specifically how the pandemic has impacted the companies timelines. Supply chains and delivery interruptions have impacted many companies during the covid pandemic. Dr. John McGraw states a big goal for Izotropic is to keep the overall timeline on track, in the meantime the company is using this time to optimize the clinical trial path.

Izotropic CEO Interview - Clinical Trials Soon? (CSE:IZO)

Izotropic CEO Dr. John McGraw joins Justin today to give a high level overview of the stages for Clinical Trials with a timeline update for Izotropic Corp. Dr John McGraw goes over what makes the IzoView so unique compared to its competitors!

Izotropic Corp - Company Profile (CSE:IZO)

Justin reviews Izotropic Corporation, a healthcare disruptor stock. In this video Justin breaks down why Izotropic might have the best ROI in the whole stock market! With IzoView, Izotropic is trying to disrupt and tackle many of the challenges currently facing the CT Breast imaging industry.

Izotropic CEO Interview - Prototype, Clinical Trial Updates! (CSE:IZO)

Izotropic CEO Dr. John McGraw sits down with Justin to discuss and give updates on the IzoView Prototype, Clinical Trials, Patent Portfolio, and Strategic Partnerships.